gsthr logo
Quick links to detailed datasheets for United States of America at gsthr.org

Smoking in United States of America

In the United States of America, smoking is allowed but tobacco products should follow some regulations. Under these regulations, health warnings on tobacco packaging including cigarettes are mandatory, the minimum legal age for their sales is 21 years, and there are no federal legal restrictions on smoking in public places. While tobacco advertising is regulated, not all forms of their advertising are banned. An excise tax of 32.16% with a total taxation rate of 37.36% is applied on cigarettes. Cigarettes can legally be sold with authorised documents. They may also be purchased through vending machines as well as through online channels. Importing cigarettes for trade is allowed with an appropriate import license. Despite these control measures, prevalence data show that smoking remains an important public health issue in the United States. There were 39.8 million current smokers in the country in 2024. This represents an overall adult smoking prevalence of 14.1%, with higher prevalence among men (17.1%) than among women (11.1%). In comparison, the overall current smoking prevalence was 12.3% in 2022. The adult daily smoking prevalence was recorded to be 10.01% in 2020. Smoking-related mortality also remains significant in the country. In 2021, smoking resulted in 360,370 deaths, including 216,986 male deaths and 143,383 female deaths. This shows that smoking accounted for 10.38% of all deaths in the United States in 2021, with a higher rate among men (11.9%) than among women (8.7%).

Read articles from United States of America

January 31, 2020 by nytimes.com

‘It’s Rampant’: Disposable Flavor Pods Are the New Thing in Vaping

The Food and Drug Administration is banning most flavored e-cigarettes, but that isn’t keeping banana ice, sour gummy or cool mint out of the hands of McCracken County High School students.

Blame a policy loophole. When the Trump administration decided to prohibit fruit, mint and dessert flavors in refillable cartridge-based e-cigarettes like Juul, it carved out a few exceptions to mollify the vape shop owners and adult consumers who complained. The much-publicized exemption allows menthol and tobacco flavors.

January 31, 2020 by cnn.com

Despite new regulations, FDA still fails to protect youth from e-cigarette epidemic, American Lung Association says

The US Food and Drug Administration received its fourth consecutive failing grade on regulation of tobacco products in the American Lung Association's annual State of Tobacco Control report.

A key factor in the grade was the Trump administration's decision to exempt menthol and tobacco-flavored e-cigarettes from the policy it finalized this month to clear the market of cartridge-based e-cigarette flavors. The final policy was a shift from its September announcement that it would clear the market of all e-cigarette flavors except tobacco.

January 30, 2020 by cspdailynews.com

NJOY to Stop Selling Fruit-Flavored E-Cigarettes

NJOY Holdings Inc., which makes NJOY Daily and other disposable electronic cigarettes, has voluntarily halted sales of its fruit-flavored products, according to a Wall Street Journal report. The decision comes as lawmakers and anti-vaping advocates raise concerns that young people may migrate to the devices, the report said.

The U.S. Food and Drug Administration (FDA) is barring most flavors, including fruit and mint, [...] But the FDA’s new policy, released Jan. 2, states that the flavor restrictions don’t apply to “completely self-contained, disposable products.”

January 30, 2020 by frontiersin.org

E-cigarette popularity on Instagram is still growing despite an FDA anti-vaping campaign

Promotional vaping Instagram posts outnumber anti-vaping content 10,000 to 1, according to a new study published in Frontiers in Communication. [...] “U.S. public health officials have been calling vaping among youth an epidemic and have been putting a lot of effort into trying to stop this epidemic by introducing #TheRealCost anti-vaping campaign,” says Julia Vassey of the University of California, Berkeley, in the United States. “But this stark imbalance in the volume of posts has caused the FDA message to be overwhelmed by marketing from the vaping brands.”

January 30, 2020 by filtermag.org

The New Federal Minimum Vaping Age Won’t Protect Young People

President Donald Trump signed legislation in December 2019 to amend the Federal Food, Drug and Cosmetic Act by raising the federal minimum age of sale for tobacco products from 18 to 21. “Tobacco products,” in this case, includes both smoked and smokeless tobacco, but also nicotine vaping products.

Protecting young people’s health was the rationale. But will raising the age of sale actually reduce harms for 18 to 20-year-olds? First we must question the inclusion of vaping products in this legislation, when the best available evidence indicates that vaping is 95 percent less harmful than smoking. [...]

January 29, 2020 by vtdigger.org

Tobacco industry targets Vermont’s proposed ban on menthol products

With Vermont lawmakers poised to pass legislation this year banning flavored nicotine and vaping products, the tobacco industry is putting its energy and money into opposing just one aspect of the bill: a ban on menthol.

Bracing for the legislation, tobacco companies have spent tens of thousands of dollars on lobbyists to prevent the forced removal of menthol cigarettes and e-cigarette products from the market. [...] in recent weeks, taking menthol cigarettes off the market has become a new priority for Democrats in Vermont, who say the products also get young people addicted to nicotine, [...]

January 29, 2020 by vapingpost.com

Podcast: CDC proper warnings; CBD bill; SF vaping ban

To lead us off this week, we turn our attention to San Francisco. Catherine Ho of The San Francisco Chronicle reports that vape shops in the city are “scrambling” to prepare for a sweeping ban on e-cigarettes and vaping products within city limits. According to the report and Vaping Post’s previous reporting, the ban takes effect on Jan. 29. The ban only covers vaping products that contain nicotine and not products that contain CBD and THC. Combustible cigarettes are also still left on the shelves of convenience stores and bodegas across the city.

January 28, 2020 by medicalxpress.com

Most young people do not vape, and even fewer vape regularly

While youth vaping rates have increased in recent years, most middle and high school students don't vape or smoke and very few vape or smoke daily, finds a study led by researchers at NYU School of Global Public Health. The study, published this month in the journal Nicotine & Tobacco Research, finds that over 80 percent of youth do not use any tobacco and over 86 percent don't vape—and among the minority who do vape, most are not regular users. In addition, the study reveals that most youth who are vaping are also current or former smokers.

January 27, 2020 by journalnow.com

U.S. Surgeon General update has mixed message on e-cigarette effectiveness

The U.S. Surgeon General released Thursday a 30-year update on smoking-cessation efforts that provided a mixed message on the effectiveness of electronic cigarettes.

E-cigarettes are not currently approved by the Food and Drug Administration as a quit-smoking aid, and are not considered as safe products for any user.

“E-cigarettes, a continually changing and diverse group of products, are used in a variety of ways,” Dr. Jerome Adams said in the 20-page consumer guide.

January 22, 2020 by thefederalist.com

Yes, The FDA Is In Trouble, But The New York Times’ Prescription Would Make It Worse

A recent New York Times editorial about the Food and Drug Administration reflects a systematic weakness at the once-venerable Gray Lady: The members of the editorial board often rely on sloganeering and popular wisdom instead of substantive evidence.

The editorial was headlined, “The FDA Is in Trouble. Here’s How to Fix It.” The agency is in trouble. But it’s due to the very kinds of “fixes” the Times recommends. The FDA is highly bureaucratic and risk averse, leading to a slow and expensive drug approval process—at last count, more than $2.5 billion to bring a new drug to market. [...]